Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Infective Endocarditis
2005 Standout
Clinical impact of antibiotic-resistant Gram-positive pathogens
2009
Vancomycin-Resistant Enterococci
2000
Liver Transplantation for Hepatocellular Carcinoma
1998
The Incidence of and Clinical Variables Associated With Vancomycin-Resistant Enterococcal Colonization in Mechanically Ventilated Patients
1999
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
2012
Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes
1998
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Infection Control and Cost Control in the Era of Managed Care
2002
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on Outcomes
2001
Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population‐based study
2009
Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-ResistantEnterococcus
2002
Vancomycin-Resistant Enterococci Outside the Health-Care Setting: Prevalence, Sources, and Public Health Implications
1997
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
2003
Resistance Patterns Among Nosocomial Pathogens
2001
Infection Control — A Problem for Patient Safety
2003 Standout
A Prospective Study to Determine Whether Cover Gowns in Addition to Gloves Decrease Nosocomial Transmission of Vancomycin-Resistant Enterococci in an Intensive Care Unit
2002
EuroSCORE II
2012 Standout
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis
2010
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance
1998
Treatment Options for Vancomycin- Resistant Enterococcal Infections
2002
Emergence and management of drug-resistant enterococcal infections
2008
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin‐Resistant Enterococcus in a Level 1 Trauma Center
2002
Vancomycin-resistant enterococci: consequences for therapy and infection control
2005
INCIDENCE AND OUTCOME OF INFECTION BY VANCOMYCIN-RESISTANTENTEROCOCCUS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1998
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Enterococcus faecium Bacteremia
1998
Non-alcoholic fatty liver disease and liver transplantation
2016
Reasons for Noncompliance With Infection Control Guidelines
2000
Vancomycin-Resistant Enterococci
2003
Global burden of liver disease: 2023 update
2023 Standout
The Role of Chloramphenicol in the Treatment of Bloodstream Infection Due to Vancomycin‐ResistantEnterococcus
1998
Effect of quinupristin/dalfopristin on the outcome of vancomycin- resistant Enterococcus faecium bacteraemia: comparison with a control cohort
1997
Enterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality
1999
Control of Endemic Vancomycin-Resistant Enterococcus among Inpatients at a University Hospital
2003
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Resistance to Glycopeptides in Enterococci
1997
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
2008 Standout
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆
2000
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
1998
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
2020 Standout
Vancomycin‐Resistant Enterococcus faecium in a Long‐Term Care Facility
1998
Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
2007
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
A Hospital Epidemic of Vancomycin-Resistant Enterococcus Risk Factors and Control
2001
Herpes Zoster
2013 Standout
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
2003
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
2002
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Hepatocellular carcinoma
2022 Standout
Impact of Vancomycin Resistance on Mortality among Patients with Neutropenia and Enterococcal Bloodstream Infection
2005
Clinical implications of antimicrobial resistance for therapy
2008
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinical Failures of Linezolid and Implications for the Clinical Microbiology Laboratory
2002
Mechanisms of Antibiotic Resistance
2016 Standout
Gut Microbiota in Health and Disease
2010 Standout
Nonalcoholic Steatohepatitis After Liver Transplantation
2019
Reference Group Choice and Antibiotic Resistance Outcomes
2004
Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study
2001
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Antimicrobial treatment of hospital-acquired pneumonia
2003
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
ADOLESCENT RESILIENCE: A Framework for Understanding Healthy Development in the Face of Risk
2004 Standout
Liver Transplantation for Malignancy
2005
Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
2004
Vancomycin-Resistant Enterococci
2000
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections
1999
Coronary artery disease in decompensated patients undergoing liver transplantation evaluation
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation
2018
Nonalcoholic Fatty Liver Disease
2015 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
2005
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of A. Pinna being referenced
Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium
1996
Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation
1996
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation
1997